A validated set of criteria based on the patient’s family history, their own CVD history, their untreated lipid levels and physical signs. The subsequent score categorizes patients by the likelihood of Familial Hypercholesterolemia (FH) diagnosis.
SUMMARY: Free, unvalidated questionnaire that can be used in assessment of asthma symptom control. The questions are from a 1995 NIH Asthma Pocket Guide referenced in the National Asthma Education and Prevention Program (NAEPP) guidelines
This tool provides suggestions for Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) studies based on body area and clinical condition. It includes contrast recommendations where applicable.
This decision tool assists with management of patients with diabetic nephropathy (diabetes mellitus-related chronic kidney disease, stages III, IV, and V). It is not intended to manage CKD patients on dialysis.
Syncope decision tool. There’s a good table with clinical features and suggested causes of syncope in the reference (see footnotes).*30-day morbidity/mortality includes death, myocardial infarction, arrhythmia, pulmonary embolism, stroke, subarachnoid hemorrhage, significant hemorrhage, anemia requiring transfusion, procedural intervention to treat a related cause of syncope, or any condition that is likely to cause the patient to return to the emergency department.